KSQ Therapeutics
Maria Torres-Castillo is an experienced scientific professional currently serving as an Associate Principal Scientist at KSQ Therapeutics, Inc., where efforts are focused on accelerating IND-enabling activities and managing technology transfer. Previous roles include Senior Scientist in Cell Process Development at Thermo Fisher Scientific, where innovative cell therapy assets were developed, and a Research Associate at Renovo Neural Inc., optimizing small molecule screening and differentiation assays. Maria has engaged in business development consulting for a biotech startup and served as a process improvement consultant at Boston Children's Hospital, aiming to enhance operational efficiency. Educational qualifications include an EMBA from MIT Sloan School of Management, a Master's in Neuroscience from Case Western Reserve University, and a Bachelor's in Chemistry from the University of Puerto Rico-Mayaguez.
KSQ Therapeutics
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed.